Schwebke JR, Sobel R, Gersten JK, Sussman SA, et al. Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303). Clin Infect Dis 2022;74:1979-1985.
PMID: 34467969